Survey highlights inadequate sexual health education for LGBTQ+ adolescents

FHS
June 17, 2024
4:46 pm

Children across the United States who identify as LGBTQ+ say the sexual health education curricula they receive is leaving them without essential information to make informed decisions about their sexual health – which could force them to seek potentially dangerous advice elsewhere.

Keytruda combination treatment for NSCLC falls short in Phase III – Pharmaceutical Technology

Share this article The Keytruda / Lynparza treatment is being studied as a first-line treatment for certain types of patients with NSCLC. Credits: Sonis Photography/Shutterstock.com

March 21, 2024

Drug price increases layered over decades: AARP analysis shows how list prices can rise by more than 700%

A new AARP analysis released Thursday shows how list prices for the 25 top Medicare Part D drugs increased by an average of 226% since

August 11, 2023

FDA approves Merck’s rare PAH drug at center of $11.5B Acceleron deal

The FDA on Tuesday cleared Merck’s pulmonary arterial hypertension treatment, which could quickly become a blockbuster for the New Jersey pharma giant. Merck will market

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.